164 related articles for article (PubMed ID: 9626826)
1. Early noninvasive identification of failed reperfusion after intravenous thrombolytic therapy in acute myocardial infarction.
Stewart JT; French JK; Théroux P; Ramanathan K; Solymoss BC; Johnson R; White HD
J Am Coll Cardiol; 1998 Jun; 31(7):1499-505. PubMed ID: 9626826
[TBL] [Abstract][Full Text] [Related]
2. A score predicts failure of reperfusion after fibrinolytic therapy for acute myocardial infarction.
French JK; Ramanathan K; Stewart JT; Gao W; Théroux P; White HD
Am Heart J; 2003 Mar; 145(3):508-14. PubMed ID: 12660675
[TBL] [Abstract][Full Text] [Related]
3. Myoglobin, creatine-kinase-MB and cardiac troponin-I 60-minute ratios predict infarct-related artery patency after thrombolysis for acute myocardial infarction: results from the Thrombolysis in Myocardial Infarction study (TIMI) 10B.
Tanasijevic MJ; Cannon CP; Antman EM; Wybenga DR; Fischer GA; Grudzien C; Gibson CM; Winkelman JW; Braunwald E
J Am Coll Cardiol; 1999 Sep; 34(3):739-47. PubMed ID: 10483955
[TBL] [Abstract][Full Text] [Related]
4. Analysis of creatine kinase, CK-MB, myoglobin, and troponin T time-activity curves for early assessment of coronary artery reperfusion after intravenous thrombolysis.
Zabel M; Hohnloser SH; Köster W; Prinz M; Kasper W; Just H
Circulation; 1993 May; 87(5):1542-50. PubMed ID: 8491009
[TBL] [Abstract][Full Text] [Related]
5. A study of biochemical markers of reperfusion early after thrombolysis for acute myocardial infarction. The PERM Study Group. Prospective Evaluation of Reperfusion Markers.
Laperche T; Steg PG; Dehoux M; Benessiano J; Grollier G; Aliot E; Mossard JM; Aubry P; Coisne D; Hanssen M
Circulation; 1995 Oct; 92(8):2079-86. PubMed ID: 7554185
[TBL] [Abstract][Full Text] [Related]
6. Myoglobin, creatine kinase MB, and cardiac troponin-I to assess reperfusion after thrombolysis for acute myocardial infarction: results from TIMI 10A.
Tanasijevic MJ; Cannon CP; Wybenga DR; Fischer GA; Grudzien C; Gibson CM; Winkelman JW; Antman EM; Braunwald E
Am Heart J; 1997 Oct; 134(4):622-30. PubMed ID: 9351728
[TBL] [Abstract][Full Text] [Related]
7. Assessment of coronary reperfusion after thrombolysis with a model combining myoglobin, creatine kinase-MB, and clinical variables. TAMI-7 Study Group. Thrombolysis and Angioplasty in Myocardial Infarction-7.
Christenson RH; Ohman EM; Topol EJ; Peck S; Newby LK; Duh SH; Kereiakes DJ; Worley SJ; Alosozana GL; Wall TC; Califf RM
Circulation; 1997 Sep; 96(6):1776-82. PubMed ID: 9323061
[TBL] [Abstract][Full Text] [Related]
8. Assessment of coronary reperfusion in patients with myocardial infarction using fatty acid binding protein concentrations in plasma.
de Groot MJ; Muijtjens AM; Simoons ML; Hermens WT; Glatz JF
Heart; 2001 Mar; 85(3):278-85. PubMed ID: 11179265
[TBL] [Abstract][Full Text] [Related]
9. Early monitoring of serum cardiac troponin I for assessment of coronary reperfusion following thrombolytic therapy.
Apple FS; Henry TD; Berger CR; Landt YA
Am J Clin Pathol; 1996 Jan; 105(1):6-10. PubMed ID: 8561090
[TBL] [Abstract][Full Text] [Related]
10. Biochemical markers of thrombolytic success. IFCC Committee on Standardization of Markers of Cardiac Damage.
Apple FS
Scand J Clin Lab Invest Suppl; 1999; 230():60-6. PubMed ID: 10389203
[TBL] [Abstract][Full Text] [Related]
11. Serum myoglobin/carbonic anhydrase III ratio as a marker of reperfusion after myocardial infarction.
Vuotikka P; Uusimaa P; Niemelä M; Väänänen K; Vuori J; Peuhkurinen K
Int J Cardiol; 2003 Oct; 91(2-3):137-44. PubMed ID: 14559123
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of streptokinase, but not tissue-type plasminogen activator, in achieving 90-minute patency after thrombolysis for acute myocardial infarction decreases with time to treatment. PERM Study Group. Prospective Evaluation of Reperfusion Markers.
Steg PG; Laperche T; Golmard JL; Juliard JM; Benamer H; Himbert D; Aubry P
J Am Coll Cardiol; 1998 Mar; 31(4):776-9. PubMed ID: 9525545
[TBL] [Abstract][Full Text] [Related]
13. Low molecular weight heparin (dalteparin) as adjuvant treatment of thrombolysis in acute myocardial infarction--a pilot study: biochemical markers in acute coronary syndromes (BIOMACS II).
Frostfeldt G; Ahlberg G; Gustafsson G; Helmius G; Lindahl B; Nygren A; Siegbahn A; Swahn E; Venge P; Wallentin L
J Am Coll Cardiol; 1999 Mar; 33(3):627-33. PubMed ID: 10080461
[TBL] [Abstract][Full Text] [Related]
14. Comparison of five cardiac markers in the detection of reperfusion after thrombolysis in acute myocardial infarction.
Lavin F; Kane M; Forde A; Gannon F; Daly K
Br Heart J; 1995 May; 73(5):422-7. PubMed ID: 7786656
[TBL] [Abstract][Full Text] [Related]
15. [Enzymatic markers of reperfusion in acute myocardial infarct. With data from the ISAM study].
Walter S; Carlsson J; Schröder R; Neuhaus KL; Sorges E; Tebbe U
Herz; 1999 Oct; 24(6):430-9. PubMed ID: 10546147
[TBL] [Abstract][Full Text] [Related]
16. Survival 12 years after randomization to streptokinase: the influence of thrombolysis in myocardial infarction flow at three to four weeks.
French JK; Hyde TA; Patel H; Amos DJ; McLaughlin SC; Webber BJ; White HD
J Am Coll Cardiol; 1999 Jul; 34(1):62-9. PubMed ID: 10399993
[TBL] [Abstract][Full Text] [Related]
17. Early behavior of biochemical markers in patients with thrombolysis in myocardial infarction grade 2 flow in the infarct artery as opposed to other flow grades after intravenous thrombolysis for acute myocardial infarction. PERM Study Group. Prospective Evaluation of Reperfusion Markers.
Laperche T; Golmard JL; Steg PG
Am Heart J; 1997 Dec; 134(6):1044-51. PubMed ID: 9424064
[TBL] [Abstract][Full Text] [Related]
18. Myoglobin levels at 12 hours identify patients at low risk for 30-day mortality after thrombolysis in acute myocardial infarction: a Thrombolysis in Myocardial Infarction 10B substudy.
Srinivas VS; Cannon CP; Gibson CM; Antman EM; Greenberg MA; Tanasijevic MJ; Murphy S; de Lemos JA; Sokol S; Braunwald E; Mueller HS
Am Heart J; 2001 Jul; 142(1):29-36. PubMed ID: 11431653
[TBL] [Abstract][Full Text] [Related]
19. Incomplete recanalization as an important determinant of Thrombolysis in Myocardial Infarction (TIMI) grade 2 flow after thrombolytic therapy for acute myocardial infarction. TEAM Investigators. Thrombolytic Trial of Eminase in Acute Myocardial Infarction.
Zahger D; Karagounis LA; Cercek B; Anderson JL; Sorensen S; Moreno F; Shah PK
Am J Cardiol; 1995 Oct; 76(11):749-52. PubMed ID: 7572648
[TBL] [Abstract][Full Text] [Related]
20. Non-invasive assessment of infarct reperfusion: the predictive power of the time to peak value of myoglobin, CKMB, and CK in serum.
Katus HA; Diederich KW; Scheffold T; Uellner M; Schwarz F; Kübler W
Eur Heart J; 1988 Jun; 9(6):619-24. PubMed ID: 3409892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
